Keyword: McKesson

Bloomberg reports that three drug-distribution giants have pitched a $10 billion settlement with state attorneys general, but the AGs want far more.

For just the second time, the DOJ indicted an opioid distributor for its role in illegally pushing pills at the height of the addiction epidemic.

As the U.S. opioid crisis raged, the public didn't know how many pills were hitting the market. Newly unsealed DEA numbers offer some answers.

A generic drug price-fixing probe has seemingly centered on drugmakers, but a new lawsuit claims distribution giant McKesson was involved, too.

Drug distributor McKesson, which has had serious opioid habits, has settled another lawsuit tying it to the nation’s opioid problems.  

The Justice Department has filed felony criminal charges against a New York pharmaceutical distributor and two of its executives.

Drug wholesaler McKesson was lashed in an FDA warning letter for shipments in which opioids had been replaced by OTC drugs.

Here is some news of note for pharmaceutical manufacturing.

Amazon's plan to jump into drug sales has hit a snag, and the retail giant has reportedly put at least one plan on ice.

Drugmakers haven't been able to reach a settlement with the cities and counties suing them over the opioid epidemic.